The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial
Abstract
Background Corticosteroids have been used to treat head injuries for more than 30 years. In 1997, findings of a systematic review suggested that these drugs reduce risk of death by 1-2%. The CRASH trial--a multicentre international collaboration--aimed to confirm or refute such an effect by recruiting 20000 patients. In May, 2004, the data monitoring committee disclosed the unmasked results to the steering committee, which stopped recruitment. Methods 10008 adults with head injury and a Glasgow coma score (GCS) of 14 or less within 8 h of injury were randomly allocated 48 h infusion of corticosteroids (methylprednisolone) or placebo. Primary outcomes were death within 2 weeks of injury and death or disability at 6 months. Prespecified subgroup analyses were based on injury severity (GCS) at randomisation and on time from injury to randomisation. Analysis was by intention to treat. Effects on outcomes within 2 weeks of randomisation are presented in this report. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN74459797. Findings Compared with placebo, the risk of death from all causes within 2 weeks was higher in the group allocated corticosteroids (1052 [21.1%] vs 893 [17.9%] deaths; relative risk 1.18 [95% CI 1.09-1.27]; p=0.0001). The relative increase in deaths due to corticosteroids did not differ by injury severity (p=0.22) or time since injury (p=0.05). Interpretation Our results show there is no reduction in mortality with…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The CRASH trial, which is a large-scale clinical study including 10 000 patients with head trauma, and other literature reviews have clearly shown that routine administration of corticosteroids at high doses or pharmacological doses (30 mg/kg methylprednisolone) to all TBI patients is not indicated or may be harmful (257, 265).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [265]
Citations
Cites
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Bracken, M. B., Shepard, M. J., Collins, W. F., Holford, T. R., Young, W., Baskin, D. S., Eisenberg, H. M., Flamm, E., Leo-Summers, L., Maroon, J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005173222001 · Cited by 2,715
Epidemiology of Trauma Deaths: A Reassessment
Sauaia, A., Moore, F. A., Moore, E. E., Moser, K. S., Brennan, R., Read, R. A., & Pons, P. T. (1995) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199502000-00006 · Cited by 1,879
Bracken, M. B. (1997) · JAMA · doi:10.1001/jama.277.20.1597 · Cited by 1,397
Bracken, M. B. (1997) · JAMA · doi:10.1001/jama.1997.03540440031029 · Cited by 1,194
Inflammatory response in acute traumatic brain injury: a double-edged sword
Morganti-Kossmann, M. C., Rancan, M., Stahel, P. F., & Kossmann, T. (2002) · Current Opinion in Critical Care · doi:10.1097/00075198-200204000-00002 · Cited by 681
Methylprednisolone for acute spinal cord injury: an inappropriate standard of care
Hurlbert, R. J. (2000) · Journal of Neurosurgery: Spine · doi:10.3171/spi.2000.93.1.0001 · Cited by 507
Murray, C. J. L., & López, A. D. (1996) · Cited by 474
Survey of critical care management of comatose, head-injured patients in the United States
Ghajar, J., Hariri, R. J., Narayan, R. K., Iacono, L. A., Firlik, K., & Patterson, R. H. (1995) · Critical Care Medicine · doi:10.1097/00003246-199503000-00023 · Cited by 283
Research works printed but not linked: 2
- Otani, 1994, Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury [Japanese], Sekitsui Sekizui J, 7, 633
- Bracken, 1999, Pharmacological interventions for acute spinal cord injury (Cochrane Review)
Cited by
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
Maas, A. I. R., Menon, D. K., Adelson, P. D., Andelic, N., Bell, M. J., Belli, A., Bragge, P., Brazinova, A., Büki, A., Chesnut, R. M., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30371-x · Cited by 2,609
Ford, I., & Norrie, J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510059 · Cited by 1,405
The far-reaching scope of neuroinflammation after traumatic brain injury
Simon, D. W., McGeachy, M. J., Bayır, H., Clark, R. S. B., Loane, D. J., & Kochanek, P. M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.13 · Cited by 1,190
Fitch, M. T., & Silver, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.014 · Cited by 1,007
Serpa Neto, A., Cardoso, S. O., Manetta, J. A., Pereira, V. G. M., Espósito, D. C., Pasqualucci, M. D. O. P., Damasceno, M. C. T., & Schultz, M. J. (2012) · JAMA · doi:10.1001/jama.2012.13730 · Cited by 843
Metadata
- Authors
- Roberts, I., Yates, D., Sandercock, P. A., Farrell, B., Wasserberg, J., Lomas, G., Cottingham, R., Svoboda, P., Brayley, N., Mazairac, G., Laloë, V., Muñoz-Sánchez, A., Arango, M. F., Hartzenberg, B. H., Khamis, H., Yutthakasemsunt, S., Komolafe, E., Olldashi, F., Yadav, Y., Murillo-Cabezas, F., Shakur‐Still, H., & Edwards, P. J.
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 364
- Issue
- 9442
- Pages
- 1321-1328
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2340669326
- Semantic Scholar
- 4b0c3005aa4e32f9ea3ef44b996d7683105a81b7
- Cited by
- 1,111
- References
- 21
- Citations by year
- 2026: 35 · 2025: 37 · 2024: 51 · 2023: 51 · 2022: 47 · 2021: 45 · 2020: 63 · 2019: 56 · 2018: 54 · 2017: 60 · 2016: 49 · 2015: 54 · 2014: 54 · 2013: 57 · 2012: 49
- FWCI
- 35.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Emergency Medicine › Trauma and Emergency Care Studies
- Keywords
- intravenous corticosteroids, methylprednisolone, traumatic brain injury, mortality, Glasgow Coma Scale, CRASH trial, corticosteroid adverse effects
- MeSH terms
- Adolescent, Adult, Double-Blind Method, Female, Glucocorticoids, Craniocerebral Trauma, Humans, Infusions, Intravenous, Male, Methylprednisolone, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Glasgow Coma Scale, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(04)17188-2
- The paper
- Roberts, I., Yates, D., Sandercock, P. A., Farrell, B., Wasserberg, J., Lomas, G., Cottingham, R., Svoboda, P., Brayley, N., Mazairac, G., Laloë, V., Muñoz-Sánchez, A., Arango, M. F., Hartzenberg, B. H., Khamis, H., Yutthakasemsunt, S., Komolafe, E., Olldashi, F., Yadav, Y., . . . Edwards, P. J. (2004). Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(04)17188-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.